Company / Operating Cash Flow
Enovis Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$217.3M
FY2025
5-year range
$113.5M / $356.1M
FY2021-FY2025
Trend
+91.4%
vs FY2024
Sector context
#83 of 164
Health Care
What the data says
At $217M, Enovis's operating cash flow ranks #83 of 164 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $114M in FY2024 to $356M in FY2023.
Based on SEC 10-K filings.
$217M in FY2025 with a 5-year CAGR of -0.8%.
Declined from $356M to $217M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Sector benchmark
#83 of 164 in Health CareTop 51% of 164This company $217.3M Sector average $1.0B
▼
-79.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.8%, indicating a declining trend.
- In FY2025, operating cash flow increased 91.4% year-over-year.
- Ranks #83 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $217.3M | +91.4% |
| FY2024 | $113.5M | -68.1% |
| FY2023 | $356.1M | +17.9% |
| FY2022 | $301.9M | -15.2% |
| FY2021 | $356.1M | +57.3% |
| FY2020 | $226.4M | +3.5% |
| FY2019 | $218.8M | -3.4% |
| FY2018 | $226.4M | -25.5% |
| FY2017 | $303.8M | +23.0% |
| FY2016 | $247.0M | -31.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026